Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SPRUCE BIOSCIENCES, INC. Director's Dealing 2023

May 26, 2023

35408_dirs_2023-05-26_d42e60b0-4205-4b9a-a714-c62eebc77d69.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SPRUCE BIOSCIENCES, INC. (SPRB)
CIK: 0001683553
Period of Report: 2023-05-25

Reporting Person: Ways Kirk (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-25 Stock Option (Right to Buy) $2.26 A 30000 Acquired 2033-05-24 Common Stock (30000) Direct

Footnotes

F1: The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2024 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan).